Additional file 1: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Xiaobo Bo (4991792)
Jie Wang (16762)
Tao Suo (325889)
Xiaoling Ni (3927122)
Han Liu (288039)
Sheng Shen (584608)
Min Li (12799)
Yueqi Wang (4962742)
Houbao Liu (4991795)
Jiejie Xu (389064)

Open link

Publication date

March 2018

DOI

10.6084/m9.figshare.6015056.v1

Abstract

Table S1. Association between CD8+ T cells infiltration and patient characteristics. (DOC 64 kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 1: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Xiaobo Bo (4991792)
Jie Wang (16762)
Tao Suo (325889)
Xiaoling Ni (3927122)
Han Liu (288039)
Sheng Shen (584608)
Min Li (12799)
Yueqi Wang (4962742)
Houbao Liu (4991795)
Jiejie Xu (389064)

Open link

Publication date

March 2018

DOI

10.6084/m9.figshare.6015056.v1

Abstract

Table S1. Association between CD8+ T cells infiltration and patient characteristics. (DOC 64 kb

Extracted data

Jingjing Duan (1423531)
Yongwei Xie (5816282)
Lijuan Qu (5816285)
Lingxiong Wang (5816288)
Shunkai Zhou (5816291)
Yu Wang (12152)
Zhongyi Fan (637580)
Shengsheng Yang (134461)
Shunchang Jiao (533205)

October 2018

Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...

Additional file 1: of Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar (6318086)
Yan Xu (14594)
Jingxia Li (69669)
Junyi He (6318092)
Jibing Chen (6318098)
Man Li (81239)
Qingling Wu (2295583)
Li Lin (111038)
Yingqing Liang (6318101)
Xiaohua Wang (255149)
Jiawei Li (559407)
Yi Hu (58993)
Yan Chen (4308)
Kecheng Xu (3373754)
Yangzhe Wu (162008)
Zhinan Yin (342680)

February 2019

Figure S1. Purity of infused allogenic Vγ9Vδ2 T cells of all 8 treatment courses is > 85%. According...

Additional file 1: of Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer

Lisa König (3580973)
Fabian Mairinger (6279713)
Oliver Hoffmann (3580964)
Ann-Kathrin Bittner (3580961)
Kurt Schmid (3491198)
Rainer Kimmig (58539)
Sabine Kasimir-Bauer (3580967)
Agnes Bankfalvi (284668)

February 2019

Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...

Additional file 2: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Xiaobo Bo (4991792)
Jie Wang (16762)
Tao Suo (325889)
Xiaoling Ni (3927122)
Han Liu (288039)
Sheng Shen (584608)
Min Li (12799)
Yueqi Wang (4962742)
Houbao Liu (4991795)
Jiejie Xu (389064)

March 2018

Figure S1. Association between CD8+ T cells and overall survival in the discovery set and validation...

Additional file 4 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb

Additional file 2: of RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

Fanny Ledys (5990285)
Quentin Klopfenstein (5990288)
Caroline Truntzer (397335)
Laurent Arnould (805607)
Julie Vincent (4738878)
Leila Bengrine (5434766)
Romain Remark (5990291)
Romain Boidot (190689)
Sylvain Ladoire (44718)
Francois Ghiringhelli (5654308)
Valentin Derangere (5990294)

November 2018

Figure S1. Immune parameters correlation. Figure S2. Impact of Ras-Raf mutationnal status tumor envi...

Additional file 1: of Immune characterization of breast cancer metastases: prognostic implications

Maria Dieci (5437085)
Vassilena Tsvetkova (5437097)
Enrico Orvieto (5437064)
Federico Piacentini (5437088)
Guido Ficarra (2339788)
Gaia Griguolo (5042417)
Federica Miglietta (5437067)
Tommaso Giarratano (5437076)
Claudia Omarini (5437070)
Serena Bonaguro (5437094)
Rocco Cappellesso (384017)
Camillo Aliberti (703434)
Grazia Vernaci (5437073)
Carlo Giorgi (5437079)
Giovanni Faggioni (42109)
Giulia Tasca (5437091)
Pierfranco Conte (5437082)
Valentina Guarneri (3562331)

June 2018

Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...

Additional file 4: of Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Minoru Miyashita (3561971)
Hironobu Sasano (368960)
Kentaro Tamaki (2440135)
Hisashi Hirakawa (3561962)
Yayoi Takahashi (3561968)
Saki Nakagawa (3561965)
Gou Watanabe (3561977)
Hiroshi Tada (822204)
Akihiko Suzuki (3561974)
Noriaki Ohuchi (360735)
Takanori Ishida (822205)

September 2015

Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...

Additional file 1: of Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Marcus Schmidt (58563)
Veronika Weyer-Elberich (4491553)
Jan Hengstler (3609683)
Anne-Sophie Heimes (3386126)
Katrin Almstedt (3386120)
Aslihan Gerhold-Ay (304871)
Antje Lebrecht (304874)
Marco Battista (304875)
Annette Hasenburg (4890235)
Ugur Sahin (133198)
Konstantine Kalogeras (3551525)
Pirkko-Liisa Kellokumpu-Lehtinen (509328)
George Fountzilas (8221)
Ralph Wirtz (3583688)
Heikki Joensuu (43841)

February 2018

Table S1. Associations between median cancer CXCL13 expression and patient and tumor characteristics...

Additional file 5 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S4. Correlations between mast cell percentage and clinic pathological features of patients wit...

Additional file 1: of Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study

Minoru Miyashita (3561971)
Hironobu Sasano (368960)
Kentaro Tamaki (2440135)
Hisashi Hirakawa (3561962)
Yayoi Takahashi (3561968)
Saki Nakagawa (3561965)
Gou Watanabe (3561977)
Hiroshi Tada (822204)
Akihiko Suzuki (3561974)
Noriaki Ohuchi (360735)
Takanori Ishida (822205)

September 2015

The correlation diagrams of CD8 + TIL, FOXP3 + TIL, and CD8/FOXP3 ratio with residual cancer burden ...

Additional file 6 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S5. Correlations between mast cell number and clinic pathological features of patients with ga...

Additional file 2: of The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

Kwan Lee (2398369)
Eun Kim (365138)
Ji Yun (5808842)
Yong Park (583109)
Sung-Im Do (5683667)
Seoung Chae (5808845)
Chan Park (114760)

October 2018

Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...

Additional file 12 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Figure S7. Kaplan-Meier plots for disease-free survival by median mast cell percentage (9.315%) or m...

Additional file 1: of Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

C. Van Berckelaer (6374693)
C. Rypens (6374696)
P. van Dam (5879516)
L. Pouillon (6374699)
M. Parizel (6374702)
K. Schats (6374705)
M. Kockx (6374708)
W. Tjalma (6374711)
P. Vermeulen (3783763)
S. Laere (6374714)
F. Bertucci (3524012)
C. Colpaert (6374717)
L. Dirix (6374720)

February 2019

Table S1. Minimum criteria required for the diagnosis of IBC. Table S2. Correlation between PD-L1 an...

Additional file 3: of A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy

Jingjing Duan (1423531)
Yongwei Xie (5816282)
Lijuan Qu (5816285)
Lingxiong Wang (5816288)
Shunkai Zhou (5816291)
Yu Wang (12152)
Zhongyi Fan (637580)
Shengsheng Yang (134461)
Shunchang Jiao (533205)

October 2018

Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...

Additional file 1: of Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar (6318086)
Yan Xu (14594)
Jingxia Li (69669)
Junyi He (6318092)
Jibing Chen (6318098)
Man Li (81239)
Qingling Wu (2295583)
Li Lin (111038)
Yingqing Liang (6318101)
Xiaohua Wang (255149)
Jiawei Li (559407)
Yi Hu (58993)
Yan Chen (4308)
Kecheng Xu (3373754)
Yangzhe Wu (162008)
Zhinan Yin (342680)

February 2019

Figure S1. Purity of infused allogenic Vγ9Vδ2 T cells of all 8 treatment courses is > 85%. According...

Lisa König (3580973)
Fabian Mairinger (6279713)
Oliver Hoffmann (3580964)
Ann-Kathrin Bittner (3580961)
Kurt Schmid (3491198)
Rainer Kimmig (58539)
Sabine Kasimir-Bauer (3580967)
Agnes Bankfalvi (284668)

February 2019

Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...

Additional file 2: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Xiaobo Bo (4991792)
Jie Wang (16762)
Tao Suo (325889)
Xiaoling Ni (3927122)
Han Liu (288039)
Sheng Shen (584608)
Min Li (12799)
Yueqi Wang (4962742)
Houbao Liu (4991795)
Jiejie Xu (389064)

March 2018

Figure S1. Association between CD8+ T cells and overall survival in the discovery set and validation...

Additional file 4 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb

Additional file 2: of RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer

Fanny Ledys (5990285)
Quentin Klopfenstein (5990288)
Caroline Truntzer (397335)
Laurent Arnould (805607)
Julie Vincent (4738878)
Leila Bengrine (5434766)
Romain Remark (5990291)
Romain Boidot (190689)
Sylvain Ladoire (44718)
Francois Ghiringhelli (5654308)
Valentin Derangere (5990294)

November 2018

Figure S1. Immune parameters correlation. Figure S2. Impact of Ras-Raf mutationnal status tumor envi...

Additional file 1: of Immune characterization of breast cancer metastases: prognostic implications

Maria Dieci (5437085)
Vassilena Tsvetkova (5437097)
Enrico Orvieto (5437064)
Federico Piacentini (5437088)
Guido Ficarra (2339788)
Gaia Griguolo (5042417)
Federica Miglietta (5437067)
Tommaso Giarratano (5437076)
Claudia Omarini (5437070)
Serena Bonaguro (5437094)
Rocco Cappellesso (384017)
Camillo Aliberti (703434)
Grazia Vernaci (5437073)
Carlo Giorgi (5437079)
Giovanni Faggioni (42109)
Giulia Tasca (5437091)
Pierfranco Conte (5437082)
Valentina Guarneri (3562331)

June 2018

Table S1. CD8 levels distribution according to tumor subtype and clinicopathological features. (DOCX...

Minoru Miyashita (3561971)
Hironobu Sasano (368960)
Kentaro Tamaki (2440135)
Hisashi Hirakawa (3561962)
Yayoi Takahashi (3561968)
Saki Nakagawa (3561965)
Gou Watanabe (3561977)
Hiroshi Tada (822204)
Akihiko Suzuki (3561974)
Noriaki Ohuchi (360735)
Takanori Ishida (822205)

September 2015

Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...

Additional file 1: of Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Marcus Schmidt (58563)
Veronika Weyer-Elberich (4491553)
Jan Hengstler (3609683)
Anne-Sophie Heimes (3386126)
Katrin Almstedt (3386120)
Aslihan Gerhold-Ay (304871)
Antje Lebrecht (304874)
Marco Battista (304875)
Annette Hasenburg (4890235)
Ugur Sahin (133198)
Konstantine Kalogeras (3551525)
Pirkko-Liisa Kellokumpu-Lehtinen (509328)
George Fountzilas (8221)
Ralph Wirtz (3583688)
Heikki Joensuu (43841)

February 2018

Table S1. Associations between median cancer CXCL13 expression and patient and tumor characteristics...

Additional file 5 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S4. Correlations between mast cell percentage and clinic pathological features of patients wit...

Minoru Miyashita (3561971)
Hironobu Sasano (368960)
Kentaro Tamaki (2440135)
Hisashi Hirakawa (3561962)
Yayoi Takahashi (3561968)
Saki Nakagawa (3561965)
Gou Watanabe (3561977)
Hiroshi Tada (822204)
Akihiko Suzuki (3561974)
Noriaki Ohuchi (360735)
Takanori Ishida (822205)

September 2015

The correlation diagrams of CD8 + TIL, FOXP3 + TIL, and CD8/FOXP3 ratio with residual cancer burden ...

Additional file 6 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Table S5. Correlations between mast cell number and clinic pathological features of patients with ga...

Additional file 2: of The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

Kwan Lee (2398369)
Eun Kim (365138)
Ji Yun (5808842)
Yong Park (583109)
Sung-Im Do (5683667)
Seoung Chae (5808845)
Chan Park (114760)

October 2018

Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...

Additional file 12 of Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-Îą-PD-L1 pathway

Yipin Lv (5847563)
Yongliang Zhao (400757)
Xianhua Wang (423878)
Na Chen (153323)
Fangyuan Mao (746320)
Yongsheng Teng (6405083)
Tingting Wang (123983)
Liusheng Peng (6405086)
Jinyu Zhang (310913)
Ping Cheng (289811)
Yugang Liu (602354)
Hui Kong (4516105)
Weisan Chen (5881)
Chuanjie Hao (6405089)
Bin Han (45760)
Qiang Ma (441889)
Quanming Zou (147799)
Jun Chen (4238)
Yuan Zhuang (478696)

February 2019

Figure S7. Kaplan-Meier plots for disease-free survival by median mast cell percentage (9.315%) or m...

Additional file 1: of Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

C. Van Berckelaer (6374693)
C. Rypens (6374696)
P. van Dam (5879516)
L. Pouillon (6374699)
M. Parizel (6374702)
K. Schats (6374705)
M. Kockx (6374708)
W. Tjalma (6374711)
P. Vermeulen (3783763)
S. Laere (6374714)
F. Bertucci (3524012)
C. Colpaert (6374717)
L. Dirix (6374720)

February 2019

Table S1. Minimum criteria required for the diagnosis of IBC. Table S2. Correlation between PD-L1 an...

Additional file 3: of A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy

Jingjing Duan (1423531)
Yongwei Xie (5816282)
Lijuan Qu (5816285)
Lingxiong Wang (5816288)
Shunkai Zhou (5816291)
Yu Wang (12152)
Zhongyi Fan (637580)
Shengsheng Yang (134461)
Shunchang Jiao (533205)

October 2018

Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...

Additional file 1: of Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar (6318086)
Yan Xu (14594)
Jingxia Li (69669)
Junyi He (6318092)
Jibing Chen (6318098)
Man Li (81239)
Qingling Wu (2295583)
Li Lin (111038)
Yingqing Liang (6318101)
Xiaohua Wang (255149)
Jiawei Li (559407)
Yi Hu (58993)
Yan Chen (4308)
Kecheng Xu (3373754)
Yangzhe Wu (162008)
Zhinan Yin (342680)

February 2019

Figure S1. Purity of infused allogenic Vγ9Vδ2 T cells of all 8 treatment courses is > 85%. According...

Lisa König (3580973)
Fabian Mairinger (6279713)
Oliver Hoffmann (3580964)
Ann-Kathrin Bittner (3580961)
Kurt Schmid (3491198)
Rainer Kimmig (58539)
Sabine Kasimir-Bauer (3580967)
Agnes Bankfalvi (284668)

February 2019

Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...

Additional file 1: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Abstract

Extracted data

Additional file 1: of Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Abstract

Extracted data

Related items

Related items